Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.
Diabetes Care. 2013 Sep;36(9):2600-6. doi: 10.2337/dc12-2158. Epub 2013 Mar 20.
Type 2 diabetes has been linked with increased risk of dementia and cognitive impairment among older adults and with premature mortality in young and middle-aged adults. No studies have evaluated the association between diabetes and dementia among Mexican Americans, a population with a high burden of diabetes. We evaluated the association of diabetes with incidence of dementia and cognitive impairment without dementia (CIND) among older Mexican Americans while accounting for competing risk from death.
This study included 1,617 participants 60-98 years of age from the Sacramento Area Latino Study on Aging followed up to 10 years from 1998. We evaluated the association between diabetes and dementia/CIND with competing risk regression models.
Participants free of dementia/CIND at baseline (n = 1,617) were followed annually up to 10 years. There were 677 (41.9%) participants with diabetes, 159 (9.8%) incident dementia/CIND cases, and 361 (22.3%) deaths. Treated and untreated diabetes (hazard ratio 2.12 [95% CI 1.65-2.73] and 2.15 [1.58-2.95]) and dementia/CIND (2.48 [1.75-3.51]) were associated with an increased risk of death. In models adjusted for competing risk of death, those with treated and untreated diabetes had an increased risk of dementia/CIND (2.05 [1.41-2.97] and 1.55 [0.93-2.58]) compared with those without diabetes.
These findings provide evidence that the association between type 2 diabetes and dementia/CIND among Mexican Americans remains strong after accounting for competing risk of mortality. Treatments that modify risk of death among those with diabetes may change future dementia risk.
2 型糖尿病与老年人痴呆和认知障碍的风险增加以及中青年人群的过早死亡有关。尚未有研究评估墨西哥裔美国人(糖尿病负担较重的人群)中糖尿病与痴呆的关系。我们评估了糖尿病与老年墨西哥裔美国人中痴呆和无痴呆性认知障碍(CIND)的发病风险之间的关联,同时考虑了死亡的竞争风险。
这项研究纳入了 1617 名年龄在 60-98 岁的来自萨克拉门托拉丁裔老龄化研究的参与者,随访时间从 1998 年开始长达 10 年。我们使用竞争风险回归模型评估了糖尿病与痴呆/CIND 之间的关联。
基线时无痴呆/CIND 的参与者(n=1617)每年随访一次,最长随访 10 年。其中有 677 名(41.9%)参与者患有糖尿病,159 名(9.8%)发生了痴呆/CIND 病例,361 名(22.3%)死亡。治疗和未治疗的糖尿病(风险比 2.12[95%CI 1.65-2.73]和 2.15[1.58-2.95])和痴呆/CIND(2.48[1.75-3.51])与死亡风险增加相关。在调整了死亡竞争风险的模型中,与无糖尿病者相比,治疗和未治疗的糖尿病者痴呆/CIND 的风险增加(2.05[1.41-2.97]和 1.55[0.93-2.58])。
这些发现提供了证据,表明在考虑到死亡率的竞争风险后,墨西哥裔美国人中 2 型糖尿病与痴呆/CIND 之间的关联仍然很强。改变糖尿病患者死亡风险的治疗方法可能会改变未来的痴呆风险。